13F-HR filed by Column Group LLC
Column Group LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 7 holding rows worth $539,375,000.
- Accession
- 0000950123-22-006494
- Filer
- CIK 1833486
- Filed
- 2022-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 7 entries on the cover page, a total value of $539,375,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $539,375,000 with VALUE read as thousands by filing date, 13F file number 028-20797. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 16,245,817 | $247,749,000 | thousands by filing date | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 9,400,290 | $110,735,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 3,347,245 | $85,388,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,402,008 | $30,830,000 | thousands by filing date | |
| Surrozen, Inc. | 86889P109 | COM | 9,414,795 | $28,339,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 3,568,181 | $19,054,000 | thousands by filing date | |
| EFFECTOR THERAPEUTICS INC | 28202V108 | COM | 4,309,329 | $17,280,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-006494 | this filing | 2022-05-16 | acceptance time not in the bulk data set |